ProMetic Life Sciences Company Profile (TSE:PLI)

About ProMetic Life Sciences

ProMetic Life Sciences logoProMetic Life Sciences Inc. (ProMetic) is a Canada-based biopharmaceutical company. The Company has two segments: Small Molecule Therapeutics and Protein Technology. The Company offers its technology platform for large-scale drug purification of biologics, drug development, proteomics and the elimination of pathogens to various industries, and uses its own affinity technology that provides for extraction and purification of therapeutic proteins from human plasma in order to develop therapeutics and orphan drugs. ProMetic is also developing its own small molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation and cancer. It has research and development facilities in the United Kingdom, the United States and Canada; manufacturing facilities in the Isle of Man and Canada, and business development activities in the United States, Europe and Asia.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: PLI
  • CUSIP:
Key Metrics:
  • Previous Close: $2.97
  • 50 Day Moving Average: $2.89
  • 200 Day Moving Average: $3.02
  • 52-Week Range: C$1.39 - C$3.62
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $1.78B
  • Outstanding Shares: 604,340,000
Additional Links:

Analyst Ratings

Consensus Ratings for ProMetic Life Sciences (TSE:PLI) (?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: C$4.89

Analysts' Ratings History for ProMetic Life Sciences (TSE:PLI)
Show:
DateFirmActionRatingPrice TargetDetails
8/25/2016ScotiabankReiterated RatingOutperformC$5.00View Rating Details
8/25/2016CIBCLower Price TargetC$5.00 -> C$4.85View Rating Details
8/25/2016Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
5/26/2016National Bank FinancialReiterated RatingOutperformC$4.90View Rating Details
3/28/2016Paradigm CapitalBoost Price TargetBuyC$2.90 -> C$3.30View Rating Details
1/29/2016Panmure GordonBoost Price TargetBuyC$6.70View Rating Details
12/1/2015Canaccord GenuityBoost Price TargetBuyC$4.25 -> C$4.75View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for ProMetic Life Sciences (TSE:PLI)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for ProMetic Life Sciences (TSE:PLI)
Current Year EPS Consensus Estimate: $-0.09 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.03)($0.03)($0.03)
Q2 20161($0.03)($0.03)($0.03)
Q3 20161($0.03)($0.03)($0.03)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for ProMetic Life Sciences (TSE:PLI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ProMetic Life Sciences (TSE:PLI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/6/2016Bruce PritchardInsiderBuy8,800C$3.19C$28,050.88
4/5/2016Bruce WendelDirectorBuy35,200C$2.45C$86,387.84
1/21/2016Raymond Manuel HakimDirectorBuy10,000C$2.77C$27,700.00
1/20/2016Pierre LaurinDirectorBuy2,000C$2.62C$5,240.00
1/19/2016Gregory WeaverInsiderBuy25,000C$2.78C$69,500.00
1/12/2016Louise M�NardDirectorBuy1,867C$2.94C$5,488.98
12/31/2015Kurt Stefan Victor ClulowDirectorBuy273,800C$3.42C$937,737.62
12/29/2015Kurt Stefan Victor ClulowDirectorBuy232,700C$3.22C$749,875.75
12/21/2015Kurt Stefan Victor ClulowDirectorBuy439,500C$3.16C$1,388,160.75
12/4/2015Gregory WeaverInsiderBuy5,000C$2.14C$10,706.50
12/3/2015Gregory WeaverInsiderBuy5,000C$2.24C$11,184.00
12/3/2015Pierre LaurinDirectorSell259,125C$2.99C$774,913.31
11/17/2015Jonathan BoothInsiderBuy25,000C$2.21C$55,225.00
9/30/2015Kurt Stefan Victor ClulowDirectorBuy50,000C$1.43C$71,500.00
9/29/2015Kurt Stefan Victor ClulowDirectorBuy153,400C$1.42C$217,889.36
9/25/2015Raymond Manuel HakimDirectorBuy15,000C$1.69C$25,399.50
9/15/2015Andrew Trevor BishopDirectorBuy10,000C$1.81C$18,100.00
9/8/2015Simon Geoffrey BestDirectorBuy30,000C$1.95C$58,464.00
8/24/2015Nancy Orr-GaucherDirectorBuy2,800C$1.75C$4,900.00
8/21/2015Pierre LaurinDirectorBuy2,400C$1.83C$4,392.00
7/16/2015Simon Geoffrey BestDirectorBuy60,000C$2.43C$145,782.00
7/15/2015Patrick SartoreInsiderSell122,736C$2.30C$282,722.38
7/15/2015Steven J BurtonDirectorSell49,842C$2.30C$114,811.05
7/2/2015Kurt Stefan Victor ClulowDirectorBuy229,900C$2.32C$533,184.08
6/30/2015Kurt Stefan Victor ClulowDirectorBuy770,100C$2.26C$1,742,736.30
6/29/2015Kurt Stefan Victor ClulowDirectorBuy114,750C$2.10C$240,435.68
6/26/2015Kurt Stefan Victor ClulowDirectorBuy885,250C$2.12C$1,879,208.70
6/16/2015Patrick SartoreInsiderBuy2,300C$2.24C$5,152.00
6/12/2015Patrick SartoreInsiderBuy4,000C$2.28C$9,122.00
6/11/2015Louise M�NardDirectorBuy10,000C$2.35C$23,500.00
6/5/2015Raymond Manuel HakimDirectorBuy50,000C$2.45C$122,495.00
6/4/2015Paul MesburisDirectorSell115,593C$2.40C$277,423.20
5/22/2015Nancy Orr-GaucherDirectorSell9,787C$2.47C$24,173.89
4/9/2015Nancy Orr-GaucherDirectorSell9,657C$2.72C$26,267.04
4/7/2015Bruce PritchardInsiderBuy10,200C$2.74C$27,943.92
2/6/2015John Edward MoranDirectorBuy64,500C$1.51C$97,395.00
1/12/2015Patrick SartoreInsiderSell279,656C$1.87C$523,348.24
1/12/2015Pierre LaurinDirectorSell956,264C$1.87C$1,789,552.45
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ProMetic Life Sciences (TSE:PLI)
DateHeadline
News IconProMetic Life Sciences, Inc. (OTCMKTS:PFSCF) Announces New Additions to its Plasminogen's Targeted Indications ... - Duncan Research (TSE:PLI)
www.duncanindependent.com - September 23 at 11:34 AM
capitalcube.com logoETF’s with exposure to ProMetic Life Sciences, Inc. : September 23, 2016 (TSE:PLI)
www.capitalcube.com - September 23 at 11:34 AM
News IconWhat's ProMetic Life Sciences Inc. Upside After Today's Huge Increase? - Post News (TSE:PLI)
www.kentuckypostnews.com - September 20 at 12:03 PM
capitalcube.com logoProMetic Life Sciences, Inc. breached its 50 day moving average in a Bullish Manner : PLI-CA : September 20, 2016 (TSE:PLI)
www.capitalcube.com - September 20 at 12:03 PM
prnewswire.com logoTelesta Therapeutics Publishes its Annual Financial Statements and Provides Date of Special Shareholders Meeting - PR Newswire (press release) (TSE:PLI)
www.prnewswire.com - September 19 at 11:19 AM
News Icon"ProMetic Life Sciences, Inc." now available at Fast Market Research (TSE:PLI)
reports.pr-inside.com - September 15 at 10:18 AM
capitalcube.com logoETF’s with exposure to ProMetic Life Sciences, Inc. : September 12, 2016 (TSE:PLI)
www.capitalcube.com - September 12 at 6:30 PM
News IconNow Available: ProMetic Life Sciences Inc. - Product Pipeline Review - 2016 (TSE:PLI)
reports.pr-inside.com - September 8 at 10:38 AM
News IconProMetic announces the addition of tympanic membrane perforations (TMPs) to its plasminogen's targeted indications - Edmonton Journal (TSE:PLI)
www.edmontonjournal.com - September 7 at 10:21 AM
News IconLatest Reports on Market Movers Air Canada, Canadian National Railway, ProMetic Life Sciences, and Tahoe Resources (TSE:PLI)
news.investornetwork.com - September 7 at 10:21 AM
News IconProMetic Life Sciences Inc. Therapeutics Pipeline Industry Review H2 2016 (TSE:PLI)
reports.pr-inside.com - September 2 at 11:40 AM
capitalcube.com logoETF’s with exposure to ProMetic Life Sciences, Inc. : August 30, 2016 (TSE:PLI)
www.capitalcube.com - August 30 at 6:45 PM
News IconProMetic Life Sciences’ Telesta acquisition gets thumbs up at Echelon (TSE:PLI)
www.cantechletter.com - August 25 at 6:57 PM
News IconProMetic Life Sci Takes Out Telesta in All Share Transaction (TSE:PLI)
www.biospace.com - August 25 at 11:56 AM
baystreet.ca logoProMetic Life Sciences (TSE:PLI)
www.baystreet.ca - August 24 at 6:35 PM
News IconTelesta Therapeutics Announces Execution of a Binding Purchase Agreement from ProMetic Life Sciences Inc. - Edmonton Journal (TSE:PLI)
www.edmontonjournal.com - August 24 at 9:54 AM
capitalcube.com logoProMetic Life Sciences, Inc. :PLI-CA: Earnings Analysis: Q2, 2016 By the Numbers : August 24, 2016 (TSE:PLI)
www.capitalcube.com - August 24 at 9:54 AM
capitalcube.com logoProMetic Life Sciences, Inc. breached its 50 day moving average in a Bearish Manner : PLI-CA : August 15, 2016 (TSE:PLI)
www.capitalcube.com - August 15 at 9:01 AM
proactiveinvestors.co.uk logoSmall Cap Wrap: Altitude Group, Avingtrans, Blue Prism, Conroy Gold and Natural Resources, Lok’n Store.. (TSE:PLI)
www.proactiveinvestors.co.uk - August 12 at 10:02 AM
reuters.com logoBRIEF-Prometic reports Q2 revenue C$3.3 million (TSE:PLI)
www.reuters.com - August 12 at 10:02 AM
investors.com logoProMetic completes enrolment of patients for pivotal trial (TSE:PLI)
www.proactiveinvestors.com - August 12 at 10:02 AM
finance.yahoo.com logoProMetic reports second quarter 2016 highlights and financial results - Yahoo Finance (TSE:PLI)
finance.yahoo.com - August 11 at 7:23 PM
investors.com logoProMetic completes enrolment of patients for pivotal trial - Proactive Investors USA & Canada (TSE:PLI)
www.proactiveinvestors.com - August 11 at 7:23 PM
News IconProMetic Life Sciences is undervalued, says Paradigm Capital (TSE:PLI)
www.cantechletter.com - August 9 at 7:07 PM
News IconProMetic Completes Adult Patients' Enrolment in Pivotal IVIG Phase 3 Clinical Trial - Montreal Gazette (TSE:PLI)
www.montrealgazette.com - August 9 at 10:02 AM
News IconPrometic to report its second quarter 2016 financial results and hold conference call / webcast - Montreal Gazette (TSE:PLI)
www.montrealgazette.com - August 3 at 10:04 AM
baystreet.ca logoResearch Report Initiated on Biotechnology Stocks ProMetic Life Sciences, Theratechnologies, NAPEC, and Oncolytics ... - Baystreet.ca (TSE:PLI)
www.baystreet.ca - August 3 at 10:04 AM
stockhouse.com logoPrometic to report its second quarter 2016 financial results and hold conference call / webcast - Stockhouse (TSE:PLI)
www.stockhouse.com - August 2 at 7:09 PM
capitalcube.com logoETF’s with exposure to ProMetic Life Sciences, Inc. : July 29, 2016 (TSE:PLI)
www.capitalcube.com - July 29 at 1:47 PM
News IconWere Analysts Bearish ProMetic Life Sciences Inc. (TSE:PLI) This Week? - Consumer Eagle (TSE:PLI)
www.consumereagle.com - July 23 at 10:44 AM
capitalcube.com logoETF’s with exposure to ProMetic Life Sciences, Inc. : July 19, 2016 (TSE:PLI)
www.capitalcube.com - July 19 at 1:00 PM
News IconHow Many ProMetic Life Sciences Inc. (TSE:PLI)'s Analysts Are Bullish? - Press Telegraph (TSE:PLI)
presstelegraph.com - July 14 at 10:28 AM
News IconA Reversal for ProMetic Life Sciences Inc. Is Not Near. The Stock Declines Again - Press Telegraph (TSE:PLI)
presstelegraph.com - July 11 at 6:49 PM
finanznachrichten.de logoHereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H1 2016 - Research and Markets (TSE:PLI)
www.finanznachrichten.de - July 8 at 9:46 AM
capitalcube.com logoProMetic Life Sciences, Inc. breached its 50 day moving average in a Bullish Manner : PLI-CA : July 8, 2016 (TSE:PLI)
www.capitalcube.com - July 8 at 8:34 AM
4-traders.com logoProMetic Life Sciences : plasminogen granted Fast Track designation by the US FDA (TSE:PLI)
www.4-traders.com - June 14 at 11:41 AM
News IconProMetic's plasminogen granted Fast Track designation by the US FDA - Edmonton Journal (TSE:PLI)
www.edmontonjournal.com - June 13 at 6:24 PM
nasdaq.com logoMood Turns Sour As TSX Logs Losing Skid -- Canadian Commentary - Nasdaq (TSE:PLI)
www.nasdaq.com - June 13 at 6:24 PM
stockhouse.com logoProMetic's plasminogen granted Fast Track designation by the US FDA - Stockhouse (TSE:PLI)
www.stockhouse.com - June 13 at 9:48 AM
investors.com logoProMetic Life Sciences to present diabetes drug data - Proactive Investors USA & Canada (TSE:PLI)
www.proactiveinvestors.com - June 9 at 9:49 AM
News IconProMetic Life Sciences Inc. (PLI) to Post FY2016 Earnings of ($0.08) Per Share, National Bank Financial Forecasts - Let Me Know About This (TSE:PLI)
www.lmkat.com - May 30 at 1:39 PM
stockhouse.com logoProMetic Life Sciences Inc. T.PLI (TSE:PLI)
www.stockhouse.com - May 28 at 11:40 AM
News IconDoes ProMetic Life Sciences Inc. Have Any Gas After Today's Huge Decline? - Wall Street Hints and News (TSE:PLI)
hintsnewsnetwork.com - May 26 at 11:49 AM
biz.yahoo.com logoQ1 2016 ProMetic Life Sciences Inc Earnings Release-Tentative - After Market Close (TSE:PLI)
biz.yahoo.com - May 11 at 7:07 AM
capitalcube.com logoProMetic Life Sciences, Inc. :PLI-CA: Earnings Analysis: Q4, 2015 By the Numbers (TSE:PLI)
www.capitalcube.com - April 5 at 11:49 AM
capitalcube.com logoProMetic Life Sciences, Inc. :PLI-CA: Earnings Analysis: 2015 By the Numbers (TSE:PLI)
www.capitalcube.com - April 5 at 10:41 AM
finance.yahoo.com logoEdited Transcript of PLI.TO earnings conference call or presentation 31-Mar-16 3:00pm GMT (TSE:PLI)
finance.yahoo.com - March 31 at 6:02 PM
baystreet.ca logoProMetic Life Sciences Inc. (TSE:PLI)
www.baystreet.ca - March 15 at 1:53 PM
thestreet.com logoThomvest Asset Management Inc. Reports Prometic Life Sciences Inc. Share Ownership Pursuant To OSC Rule 62-504 (TSE:PLI)
www.thestreet.com - March 11 at 7:40 PM
capitalcube.com logoProMetic Life Sciences, Inc. breached its 50 day moving average in a Bullish Manner : PLI-CA : March 3, 2016 (TSE:PLI)
www.capitalcube.com - March 3 at 8:35 AM

Social

ProMetic Life Sciences (TSE:PLI) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff